Is fibrinogen concentrate useful for bleeding in high-risk cardiac surgery? In a study conducted in The Netherlands, [1] 647 patients (from 2011 to 2015) scheduled to have high-risk cardiac surgery ...
Fesilty is expected to be available in the first half of 2026. The Food and Drug Administration (FDA) has approved Fesilty ™ (fibrinogen, human-chmt) for the treatment of acute bleeding episodes in ...
The FDA has approved a new fibrinogen concentrate — fibrinogen, human-chmt (Fesilty, Grifols Therapeutics, LLC) — for the treatment of acute bleeding episodes in pediatric and adult patients with ...
Research shows gut metabolite TMAO binds fibrinogen, promoting stable clots and increasing atherosclerosis risk. Learn more.
Evidence has linked fibrinogen to increased amyloid plaque deposition around the brain’s vasculature, a poorly understood condition termed cerebral amyloid angiopathy (CAA). Now, scientists led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results